Bosh sahifaGLENMARK • NSE
add
Glenmark Pharmaceuticals Ltd
Yopilish kursi
1 965,90 ₹
Kunlik diapazon
1 960,10 ₹ - 1 984,90 ₹
Yillik diapazon
1 275,50 ₹ - 2 284,80 ₹
Bozor kapitalizatsiyasi
557,52 mlrd INR
Oʻrtacha hajm
1,08 mln
Narx/foyda
55,22
Dividend daromadliligi
0,19%
Asosiy maydon
NSE
Bozor yangiliklari
The Wall Street Journal
55 daqiqa oldin
Stock Market Today: Dow Gains; Bond Yields Rise — Live Updates
0,013%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 60,47 mlrd | 76,10% |
Joriy xarajat | 25,64 mlrd | 36,23% |
Sof foyda | 6,10 mlrd | 72,31% |
Sof foyda marjasi | 10,09 | -2,23% |
Har bir ulushga tushum | — | — |
EBITDA | 23,54 mlrd | 291,88% |
Amaldagi soliq stavkasi | 36,90% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 26,90 mlrd | 47,80% |
Jami aktivlari | 190,02 mlrd | 24,72% |
Jami passivlari | 94,20 mlrd | 38,74% |
Umumiy kapital | 95,82 mlrd | — |
Tarqatilgan aksiyalar | 282,18 mln | — |
Narxi/balansdagi bahosi | 5,79 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 50,13% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 6,10 mlrd | 72,31% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Wikipedia
Tashkil etilgan
18-noy, 1977
Xodimlar soni
15 800
